FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9882511000001102: Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31790301000001115 Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
31790401000001111 Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Is pack of Senncalax tablets (Galpharm International Ltd) false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Is a Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has active ingredient Cascara false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has active ingredient Senna leaf powdered false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has excipient Beeswax false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Legal category General sales list true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has AMP Senncalax tablets (Galpharm International Ltd) true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has specific active ingredient Cascara dry extract true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has specific active ingredient Senna leaf powdered true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start